Caseware UK (AP4) 2022.0.179 2022.0.179 2023-03-3163372023-03-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.falseThe principal activity of the LLP during the year was that of a pharmacy.2022-04-0199truefalse OC379767 2022-04-01 2023-03-31 OC379767 2021-04-01 2022-03-31 OC379767 2023-03-31 OC379767 2022-03-31 OC379767 c:Buildings c:LongLeaseholdAssets 2022-04-01 2023-03-31 OC379767 c:Buildings c:LongLeaseholdAssets 2023-03-31 OC379767 c:Buildings c:LongLeaseholdAssets 2022-03-31 OC379767 c:PlantMachinery 2022-04-01 2023-03-31 OC379767 c:PlantMachinery 2023-03-31 OC379767 c:PlantMachinery 2022-03-31 OC379767 c:PlantMachinery c:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 OC379767 c:FurnitureFittings 2022-04-01 2023-03-31 OC379767 c:ComputerEquipment 2022-04-01 2023-03-31 OC379767 c:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 OC379767 c:PatentsTrademarksLicencesConcessionsSimilar 2023-03-31 OC379767 c:PatentsTrademarksLicencesConcessionsSimilar 2022-03-31 OC379767 c:CurrentFinancialInstruments 2023-03-31 OC379767 c:CurrentFinancialInstruments 2022-03-31 OC379767 c:Non-currentFinancialInstruments 2023-03-31 OC379767 c:Non-currentFinancialInstruments 2022-03-31 OC379767 c:CurrentFinancialInstruments c:WithinOneYear 2023-03-31 OC379767 c:CurrentFinancialInstruments c:WithinOneYear 2022-03-31 OC379767 c:Non-currentFinancialInstruments c:AfterOneYear 2023-03-31 OC379767 c:Non-currentFinancialInstruments c:AfterOneYear 2022-03-31 OC379767 c:Non-currentFinancialInstruments c:BetweenOneTwoYears 2023-03-31 OC379767 c:Non-currentFinancialInstruments c:BetweenOneTwoYears 2022-03-31 OC379767 c:Non-currentFinancialInstruments c:BetweenTwoFiveYears 2023-03-31 OC379767 c:Non-currentFinancialInstruments c:BetweenTwoFiveYears 2022-03-31 OC379767 d:UnitedKingdom 2022-04-01 2023-03-31 OC379767 d:UnitedKingdom 2021-04-01 2022-03-31 OC379767 c:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2023-03-31 OC379767 c:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2022-03-31 OC379767 c:FinancialLiabilitiesFairValueThroughProfitOrLoss c:UnlistedNon-exchangeTraded 2023-03-31 OC379767 c:FinancialLiabilitiesFairValueThroughProfitOrLoss c:UnlistedNon-exchangeTraded 2022-03-31 OC379767 e:FRS102 2022-04-01 2023-03-31 OC379767 e:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 OC379767 e:FullAccounts 2022-04-01 2023-03-31 OC379767 e:LimitedLiabilityPartnershipLLP 2022-04-01 2023-03-31 OC379767 c:WithinOneYear 2023-03-31 OC379767 c:WithinOneYear 2022-03-31 OC379767 c:BetweenOneFiveYears 2023-03-31 OC379767 c:BetweenOneFiveYears 2022-03-31 OC379767 c:MoreThanFiveYears 2023-03-31 OC379767 c:MoreThanFiveYears 2022-03-31 OC379767 c:PatentsTrademarksLicencesConcessionsSimilar c:OwnedIntangibleAssets 2022-04-01 2023-03-31 OC379767 e:PartnerLLP1 2022-04-01 2023-03-31 OC379767 e:PartnerLLP2 2022-04-01 2023-03-31 OC379767 c:OtherCapitalInstrumentsClassifiedAsEquity 2023-03-31 OC379767 c:OtherCapitalInstrumentsClassifiedAsEquity 2022-03-31 OC379767 c:FurtherSpecificReserve2ComponentTotalEquity 2023-03-31 OC379767 c:FurtherSpecificReserve2ComponentTotalEquity 2022-03-31 OC379767 c:FurtherSpecificReserve3ComponentTotalEquity 2023-03-31 OC379767 c:FurtherSpecificReserve3ComponentTotalEquity 2022-03-31 OC379767 f:PoundSterling 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure

Registered number: OC379767









ARLINGTON ROAD HEALTHCARE LLP







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

 
ARLINGTON ROAD HEALTHCARE LLP
 

INFORMATION




Designated Members

Community Pharmacies (UK) Limited
Arlington Road Medical LLP

LLP registered number

OC379767

Registered office

2 Peterwood WayCroydonSurreyCR0 4UQ


 
ARLINGTON ROAD HEALTHCARE LLP
 

CONTENTS



Page
Members' Report
1
Statement of Comprehensive Income
2
Statement of Financial Position
3 - 4
Reconciliation of Members' Interests
5 - 6
Notes to the Financial Statements
7 - 18


 
ARLINGTON ROAD HEALTHCARE LLP
 
  
MEMBERS' REPORT
FOR THE YEAR ENDED 31 MARCH 2023

The Members present their annual report together with the financial statements of Arlington Road Healthcare LLP ("the LLP") for the year ended 31 March 2023
 

Principal activities
 
 
The principal activity of the LLP during the year was that of a pharmacy.
 
 
Designated Members
 
 
The Designated Members who held office during the year ended and up to the date of signature of the financial statements were as follows:
Arlington Road Medical LLP
Community Pharmacies (UK) Limited
 

 
Members' capital and interests
 
 
Each Member's subscription to the capital of the LLP is determined in accordance with the terms of the LLP Agreement.
 
 
Details of changes in Members' capital in the year ended 31 March 2023 are set out in the Reconciliation of Members' Interests.
 
 
Members are remunerated from the profits of the LLP and are required to make their own provision for tax, pensions and other benefits. Profits are allocated and divided between Members after finalisation of the financial statements. Members may draw a proportion of their profit share monthly during the year in which it is made, with the balance of profits being distributed after the year end, subject to the cash requirements of the business.
 

This report was approved by the Members and signed on their behalf by: 






................................................
Community Pharmacies (UK) Limited 
Designated Member

Date: 20 November 2023
Page 1

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2023

2023
2022
Note
£
£

  

Turnover
 4 
999,741
901,834

Cost of sales
  
(639,149)
(592,299)

Gross profit
  
 
360,592
 
309,535

Administrative expenses
  
(317,247)
(285,008)

Operating profit
  
 
43,345
 
24,527

Interest payable and similar expenses
  
(8,160)
(4,345)

Profit/(loss) before tax
  
 
35,185
 
20,182

Profit/(loss) for the year before members' remuneration and profit shares
  
 
35,185
 
20,182

Profit for the year before members' remuneration and profit shares
  
35,185
20,182

Members' remuneration charged as an expense
  
(35,185)
(26,519)

Profit/(loss) for the financial year available for discretionary division among members
  
 
-
 
(6,337)

There was no other comprehensive income for 2023(2022:£NIL).

The notes on pages 7 to 18 form part of these financial statements.

Page 2

 
ARLINGTON ROAD HEALTHCARE LLP
REGISTERED NUMBER: OC379767

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2023

2023
2022
Note
£
£

Fixed assets
  

Intangible assets
 7 
2,029
2,050

Tangible assets
 8 
143,975
157,816

  
146,004
159,866

Current assets
  

Stocks
 9 
56,781
32,530

Debtors: amounts falling due within one year
 10 
121,144
98,298

Cash at bank and in hand
 11 
882
2,026

  
178,807
132,854

Creditors: amounts falling due within one year
 12 
(296,497)
(247,513)

Net current liabilities
  
 
 
(117,690)
 
 
(114,659)

Total assets less current liabilities
  
28,314
45,207

Creditors: amounts falling due after more than one year
 13 
(107,165)
(129,495)

  
(78,851)
(84,288)

  

Net liabilities
  
(78,851)
(84,288)

Page 3

 
ARLINGTON ROAD HEALTHCARE LLP
REGISTERED NUMBER: OC379767
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2023

2023
2022
Note
£
£

Represented by:
  

Loans and other debts due to members within one year
  

Amounts due in respect of profits
  
8,047
117

Other amounts
  
158,462
160,955

  
166,509
161,072

Members' other interests
  

Members' capital classified as equity
  
2
2

Other reserves

  

(245,362)
(245,362)

  
 
(245,360)
 
(245,360)

  
(78,851)
(84,288)


Total members' interests
  

Loans and other debts due to Members
  
166,509
161,072

Members' other interests
  
(245,360)
(245,360)

  
(78,851)
(84,288)


The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small LLPs regime.

The entity was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

The Members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008, with respect to accounting records and the preparation of financial statements.

The financial statements were approved and authorised for issue by the Members and were signed on their behalf by: 


................................................
Community Pharmacies (UK) Limited
Designated Member

Date: 20 November 2023

The notes on pages 7 to 18 form part of these financial statements.

Page 4

 
ARLINGTON ROAD HEALTHCARE LLP
 

RECONCILIATION OF MEMBERS' INTERESTS
FOR THE YEAR ENDED 31 MARCH 2023








EQUITY
Members' other interests
DEBT
Loans and other debts due to members less any amounts due from members in debtors
Total members' interests
Members' capital (classified as equity)
Other reserves
Total
Amounts due in respect of profits
Other amounts
Total
Total

£
£
£
£
£
£
£

Amounts due to/(from) Members 

116
180,923
181,039


Balance at 1 April 2021 

2
(239,025)
(239,023)
117
180,922
181,039
(57,984)

Loss for the year available for discretionary division among Members
 
-
(6,337)
(6,337)
-
-
-
(6,337)

Members' remuneration charged as an expense
-
-
-
-
26,519
26,519
26,519

Drawings
-
-
-
-
(26,519)
(26,519)
(26,519)

Amounts introduced by Members
-
-
-
-
1,533
1,533
1,533

Repayment of debt
 
-
-
-
-
(21,500)
(21,500)
(21,500)

Amounts due to/ (from) Members
 



117
160,955
161,072


Balance at 31 March 2022
 
2
(245,362)
(245,360)
117
160,955
161,072
(84,288)

Members' remuneration charged as an expense
-
-
-
7,930
27,255
35,185
35,185

Drawings
-
-
-
-
(27,255)
(27,255)
(27,255)

Repayment of debt
 
-
-
-
-
(2,493)
(2,493)
(2,493)

Amounts due to Members
 



8,047
158,462
166,509


Balance at 31 March 2023 
2
(245,362)
(245,360)
8,047
158,462
166,509
(78,851)

Page 5

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

RECONCILIATION OF MEMBERS' INTERESTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023

The notes on pages 7 to 18 form part of these financial statements.

There are no existing restrictions or limitations which impact the ability of the Members of the LLP to reduce the amount of Members' other interests.

Page 6

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1.


General information

Arlington Road Healthcare LLP ("the LLP") is a limited liability partnership incorporated in England and Wales. The registered office is 2 Peterwood Way, Croydon, Surrey, United Kingdom, CR0 4UQ.
The LLP's principal activities and nature of its operations are disclosed in the Members' Report.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006 and the requirements of the Statement of Recommended Practice "Accounting by Limited Liability Partnerships".

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the LLP's accounting policies (see note 3).

The financial statements are prepared in sterling, which is the functional currency of the limited liability partnership. Monetary amounts in these financial statements are rounded to the nearest £.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements have been prepared on a going concern basis which assumes the LLP will continue to be able to meet its financial obligations as they fall due.
The pharmacy continues to trade in line with expectations both financially and operationally. The Members believe the LLP has sufficient current and future cash reserves and facilities available for it to meet its liabilities including financing obligations.
The Members will continue to provide additional financial support to the business, if required, to ensure that it is able to meet its financial obligations as they fall due.

 
2.3

Turnover

Turnover is shown, net of Value Added Tax, for goods and services provided to customers.

Page 7

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

2.Accounting policies (continued)

  
2.4

Members' participation rights

Members' participation rights are the rights of a Member against the LLP that arise under the Members' agreement (for example, in respect of amounts subscribed or otherwise contributed, remuneration and profits).
Members' participation rights in the earnings or assets of the LLP are analysed between those that are, from the LLP's perspective, either a financial liability or equity, in accordance with section 22 of FRS 102. Members' participation rights, including amounts subscribed or otherwise contributed by members, for example Members' capital, are classed as liabilities unless the LLP has an unconditional right to refuse payment to Members, in which case they are classified as equity.
All amounts due to Members that are classified as liabilities are presented within 'Loans and other debts due to Members' and, where such an amount relates to current year profits, they are recognised within ‘Members' remuneration charged as an expense’ in arriving at the relevant year’s result. Unallocated amounts that are classified as equity are shown within ‘Members' other interests’. Amounts recoverable from Members are presented as debtors and shown as amounts due from Members within Members’ interests.
Where there exists an asset and liability component in respect of an individual Member’s participation rights, they are presented on a gross basis unless the LLP has both a legally enforceable right to set off the recognised amounts and it intends either to settle on a net basis or to settle and realise these amounts simultaneously, in which case they are presented net.
Whilst the Members’ agreement does not differentiate between profits and losses for profit sharing purposes, it does stipulate that the LLP cannot demand additional contributions from Members and as a result the LLP does not have an unconditional right to demand payment from Members for losses. Therefore, they are not recognised as a recoverable asset and so remain within equity as other reserves.
Other amounts applied to Members, for example remuneration paid under an employment contract and interest on capital balances, are treated in the same way as all other divisions of profits, as described above, according to whether the LLP has, in each case, an unconditional right to refuse payment. Amounts payable to Members under employment contracts and unavoidable interest on Members capital are charged to “Members remuneration charged as an expense” in the relevant year.

 
2.5

Operating leases: the LLP as lessee

Rentals paid under operating leases are charged to the Statement of Comprehensive Income on a straight-line basis over the lease term.

 
2.6

Finance costs

Finance costs are charged to the Statement of Comprehensive Income over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 8

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

2.Accounting policies (continued)

 
2.7

Borrowing costs

All borrowing costs are recognised in the Statement of Comprehensive Income in the year in which they are incurred.

 
2.8

Pensions

Defined contribution pension plan
The LLP operates a defined contribution pension plan for its employees. A defined contribution pension plan is a pension plan under which the LLP pays fixed contributions into a separate entity. Once the contributions have been paid the LLP has no further payment obligations.
The contributions are recognised as an expense in the Statement of Comprehensive Income when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the LLP in independently administered funds.

 
2.9

Intangible assets

Intangible assets comprise a licence to trade as a pharmacy. Intangible assets are stated at cost less
amortisation and are reviewed for impairment whenever there is an indication that the carrying value may be impaired.
All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.
The estimated useful lives range as follows:
        Licence                                 -         100 years

 
2.10

Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

Leasehold property
-
7%
straight-line
Fixtures and fittings
-
20%
straight-line
Computer equipment
-
33%
straight-line

The assets' residual values, useful lives and depreciation methods are reviewed and, if appropriate, adjusted prospectively if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Comprehensive Income.

Page 9

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

2.Accounting policies (continued)

 
2.11

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amounts of stocks over their estimated selling price less costs to complete and sell is recognised as an impairment loss in the Statement of Comprehensive Income. Reversals of impairment losses are also recognised in the Statement of Comprehensive Income.

 
2.12

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.13

Cash and cash equivalents

Cash and cash equivalents include cash in hand and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. 

 
2.14

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.15

Financial instruments

The LLP only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Comprehensive Income.
For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the LLP would receive for the asset if it were to be sold at the reporting date.
Financial assets and liabilities are offset and the net amount reported in the Statement of Financial Position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Page 10

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

2.Accounting policies (continued)

  
2.16

Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the LLP is demonstrably committed to terminate the employment of an employee or to provide termination benefits.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

In the application of the LLP's accounting policies, which are described in note 2, the Members are
required to make judgements, estimates and assumptions about the carrying amounts of assets and
liabilities that are not readily apparent from other sources. The estimates and associated assumptions are
based on historical experience and other factors that are considered to be relevant. Actual results may
differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting
estimates are recognised in the period in which the estimate is revised if the revision affects only that
period, or in the period of the revision and future periods if the revision affects both current and future
periods.
There are no critical judgements and estimations that the Members have made in the process of applying
the LLP's accounting policies and that have the most significant effect on the amounts recognised in
the financial statements.


4.


Turnover

The whole of the turnover is attributable to be that of retail pharmacy.

Analysis of turnover by country of destination:

2023
2022
£
£

United Kingdom
999,741
901,834

999,741
901,834


Page 11

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

5.


Employees

The average monthly number of persons (including Members with contracts of employment) employed during the year was as follows:


        2023
        2022
            No.
            No.







Pharmacy staff
9
9


6.


Information in relation to Members

2023
2022
£
£


Remuneration under an employment contract
9,985
9,006

Remuneration under participation rights
7,930
-

Mandatory interest payments
17,270
17,513

35,185
26,519




Page 12

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

7.


Intangible assets




Licence

£



Cost


At 1 April 2022
2,101



At 31 March 2023

2,101



Amortisation


At 1 April 2022
51


Charge for the year on owned assets
21



At 31 March 2023

72



Net book value



At 31 March 2023
2,029



At 31 March 2022
2,050



Page 13

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

8.


Tangible fixed assets





Leasehold property
Fixtures and fittings and Computer equipment
Total

£
£
£



Cost 


At 1 April 2022
244,381
24,272
268,653


Additions
-
900
900



At 31 March 2023

244,381
25,172
269,553



Depreciation


At 1 April 2022
89,097
21,740
110,837


Charge for the year on owned assets
14,132
609
14,741



At 31 March 2023

103,229
22,349
125,578



Net book value



At 31 March 2023
141,152
2,823
143,975



At 31 March 2022
155,284
2,532
157,816


9.


Stocks

2023
2022
£
£

Finished goods and goods for resale
56,781
32,530

56,781
32,530


Stock recognised as an expense in cost of sales during the year was £639,149 (2022 - £592,299).

Page 14

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

10.


Debtors

2023
2022
£
£


Trade debtors
105,295
75,659

Other debtors
14,466
14,131

Prepayments and accrued income
1,383
8,508

121,144
98,298



11.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
882
2,026

Less: bank overdrafts
(76,317)
(55,341)

(75,435)
(53,315)



12.


Creditors: Amounts falling due within one year

2023
2022
£
£

Bank overdrafts
76,317
55,341

Bank loans
28,721
28,721

Trade creditors
174,453
148,799

Other taxation and social security
3,081
4,205

Other creditors
7,049
6,349

Accruals and deferred income
6,876
4,098

296,497
247,513


Bank loans and overdrafts for which security has been given amounted to £105,038 (2022 - £84,062).

Page 15

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

13.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Bank loans
107,165
129,495

107,165
129,495


The aggregate amount of creditors, falling due after more than one year, for which security has been given amounted to £107,165 (2022 - £129,495).
The bank loan is repayable by equal monthly instalments. Interest will be charged at 2% per annum over the Base Rate. 
The following securities have been given:
(a) Debenture comprising fixed and floating charges over all the assets and undertaking of the LLP, both present and future,
(b) Guarantee in favour of the Bank from Day Lewis Plc guaranteeing all liabilities of the LLP limited to £125,000,
(c) Guarantee in favour of the Bank from Dr. R W Deery, Dr. P G Williams, Dr. M J Jones, Dr. R D Higgs, Dr. P A Frisby, Dr. D A Davidson and Dr. J A Lofts guaranteeing all liabilities of the LLP limited to £125,000.
Included within creditors falling due after more than one year is an amount of £nil 
(2022 - £nil) in respect of liabilities which fall due for payment after more than five years from the Balance Sheet date.


14.


Loans and other debts due to Members

In the event of a winding up the amounts included in "Loans and other debts due to Members" will rank equally with unsecured creditors.

Page 16

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

15.


Loans


Analysis of the maturity of loans is given below:


2023
2022
£
£

Amounts falling due within one year

Bank loans
28,721
28,721


28,721
28,721

Amounts falling due 1-2 years

Bank loans
28,721
28,721


28,721
28,721

Amounts falling due 2-5 years

Bank loans
78,444
100,774


78,444
100,774


135,886
158,216



16.


Financial instruments

2023
2022
£
£

Financial assets


Financial assets measured at fair value through profit or loss
882
2,026


Financial liabilities


Financial liabilities measured at fair value
(212,203)
(213,557)


17.


Pension commitments

The LLP operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the LLP in an independently administered fund. The pension cost charge represents contributions payable by the LLP to the fund and amounted to £3,754 (2022 - £3,766). Contributions totalling £655 (2022 - £711) were payable to the fund at the Balance Sheet date and are included in creditors.

Page 17

 
ARLINGTON ROAD HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

18.


Commitments under operating leases

At 31 March 2023 the LLP had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2023
2022
£
£


Not later than 1 year
12,187
9,222

Later than 1 year and not later than 5 years
39,840
36,889

Later than 5 years
-
91,590

52,027
137,701


19.


Related party transactions

Community Pharmacies (UK) Limited is a designated Member.
During the year management charges payable to Community Pharmacies (UK) Limited amounted to £9,985 
(2022 - £9,006).
During the year expenses totalling £22,168 
(2022 - £35,495) were paid by Community Pharmacies (UK) Limited. As at 31 March 2023 the LLP owed £1,462 to (2022 - £3,955) Community Pharmacies (UK) Limited. 
Other debts due to Members include £117,000 
(2022 - £117,000) owed to Community Pharmacies (UK) Limited. Interest charged on the loan during the year amounted to £12,870 (2022 - £13,113).
Arlington Road Medical LLP is a designated Member.
The LLP rents the pharmacy property from certain Members of Arlington Road Medical LLP. The total expense during the period was £9,223 
(2022 - £8,877).
Other debts due to Members include £40,000 
(2022 - £40,000) owed to Arlington Road Medical LLP. Interest charged on the loan during the year amounted to £4,400 (2022 - £4,400).
During the year the LLP made purchases totalling £373,834 
(2022 - £320,967) from Day Lewis Medical Limited, a fellow subsidiary of the parent company of Community Pharmacies (UK) Limited, Day Lewis Plc. As at 31 March 2023 the LLP owed £95,232 (2022 - £54,680) to Day Lewis Medical Limited.

Page 18